Q1 2023 Holdings
Filed 2023-05-15 | 72 holdings | $242.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus NV | EQUITIES | N5749R100 | $12.3M | 668,784 | 5.1% |
| MacroGenics Inc(MGNX) | EQUITIES | 556099109 | $9.8M | 1,361,809 | 4.0% |
| Viewray Inc(VRAYQ) | EQUITIES | 92672L107 | $9.7M | 2,793,748 | 4.0% |
| Poseida Therapeutics Inc(PSTXUSD) | EQUITIES | 73730P108 | $8.3M | 2,689,301 | 3.4% |
| Oric Pharmaceuticals Inc(ORIC) | EQUITIES | 68622P109 | $8.2M | 1,435,945 | 3.4% |
| Terns Pharmaceuticals Inc(TERN) | EQUITIES | 880881107 | $7.9M | 667,922 | 3.3% |
| Akero Therapeutics Inc(AKRO) | EQUITIES | 00973Y108 | $7.7M | 202,561 | 3.2% |
| Nuvalent Inc(NUVL) | EQUITIES | 670703107 | $7.3M | 281,533 | 3.0% |
| Bellus Health Inc(BLU) | EQUITIES | 07987C204 | $7.2M | 1,000,000 | 3.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | EQUITIES | 46116X101 | $6.8M | 125,035 | 2.8% |
| 89bio Inc(ETNBGBP) | EQUITIES | 282559103 | $6.7M | 438,215 | 2.8% |
| Viking Therapeutics Inc(VKTX) | EQUITIES | 92686J106 | $6.3M | 380,000 | 2.6% |
| Cogent Biosciences Inc(COGT) | EQUITIES | 19240Q201 | $6.3M | 579,264 | 2.6% |
| Karyopharm Therapeutics Inc(KPTIEUR) | EQUITIES | 48576U106 | $6.0M | 1,541,426 | 2.5% |
| KalVista Pharmaceuticals Inc(KALV) | EQUITIES | 483497103 | $5.7M | 723,544 | 2.3% |
| Schrodinger Inc(SDGR) | EQUITIES | 80810D103 | $5.6M | 212,825 | 2.3% |
| Pliant Therapeutics, Inc(PLRX)Call | LONG OPTION CALLS | 729139105 | $5.3M | 199,600 | 2.2% |
| Aclaris Therapeutics, Inc(ACRS)Call | LONG OPTION CALLS | 00461U105 | $5.3M | 651,400 | 2.2% |
| Gilead Sciences Inc(GILD) | EQUITIES | 375558103 | $5.0M | 60,130 | 2.1% |
| BioCryst Pharmaceuticals Inc(BCRX) | EQUITIES | 09058V103 | $4.8M | 577,757 | 2.0% |
| Veracyte Inc(VCYT) | EQUITIES | 92337F107 | $4.7M | 209,653 | 1.9% |
| Pharvaris NV(PHVS) | EQUITIES | N69605108 | $4.5M | 559,387 | 1.9% |
| ImmunoGen, Inc(IMGNEUR)Call | LONG OPTION CALLS | 45253H101 | $4.3M | 1,128,200 | 1.8% |
| United Therapeutics Corp(UTHR) | EQUITIES | 91307C102 | $4.2M | 18,578 | 1.7% |
| Vertex Pharmaceuticals Inc(VRTX) | EQUITIES | 92532F100 | $4.2M | 13,181 | 1.7% |
| Regeneron Pharmaceuticals Inc(REGN) | EQUITIES | 75886F107 | $4.1M | 5,000 | 1.7% |
| Xenon Pharmaceuticals Inc(XENE) | EQUITIES | 98420N105 | $3.5M | 96,643 | 1.4% |
| Cerus Corp(CERS) | EQUITIES | 157085101 | $3.4M | 1,152,902 | 1.4% |
| Biogen Idec Inc(BIIB) | EQUITIES | 09062X103 | $3.1M | 11,311 | 1.3% |
| 89bio, Inc(ETNBGBP)Call | LONG OPTION CALLS | 282559103 | $3.0M | 200,000 | 1.3% |
| Celldex Therapeutics Inc(CLDX) | EQUITIES | 15117B202 | $3.0M | 84,651 | 1.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | EQUITIES | 02043Q107 | $2.8M | 14,043 | 1.2% |
| Krystal Biotech Inc(KRYS) | EQUITIES | 501147102 | $2.7M | 34,014 | 1.1% |
| Cullinan Oncology Inc(CGEM) | EQUITIES | 230031106 | $2.7M | 265,032 | 1.1% |
| Pliant Therapeutics Inc(PLRX) | EQUITIES | 729139105 | $2.7M | 100,000 | 1.1% |
| Mirum Pharmaceuticals Inc(MIRM) | EQUITIES | 604749101 | $2.5M | 105,939 | 1.1% |
| Incyte Corp(INCY) | EQUITIES | 45337C102 | $2.5M | 33,938 | 1.0% |
| Insmed Inc(INSM) | EQUITIES | 457669307 | $2.5M | 143,794 | 1.0% |
| Protagonist Therapeutics Inc(PTGX) | EQUITIES | 74366E102 | $2.4M | 105,486 | 1.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | EQUITIES | 558868105 | $2.4M | 10,000 | 1.0% |
| Ventyx Biosciences Inc(VTYX) | EQUITIES | 92332V107 | $2.3M | 70,000 | 1.0% |
| MoonLake Immunotherapeutics(MLTX) | EQUITIES | 61559X104 | $2.3M | 105,750 | 0.9% |
| Mersana Therapeutics Inc | EQUITIES | 59045L106 | $2.2M | 540,059 | 0.9% |
| Immatics Nv(IMTX) | EQUITIES | N44445109 | $1.9M | 282,432 | 0.8% |
| Morphic Holding Inc | EQUITIES | 61775R105 | $1.9M | 51,684 | 0.8% |
| Aclaris Therapeutics Inc(ACRS) | EQUITIES | 00461U105 | $1.8M | 220,100 | 0.7% |
| Altimmune, Inc(ALT)Call | LONG OPTION CALLS | 02155H200 | $1.8M | 415,700 | 0.7% |
| Trevi Therapeutics Inc(TRVI) | EQUITIES | 89532M101 | $1.6M | 885,924 | 0.7% |
| Prometheus Biosciences Inc | EQUITIES | 74349U108 | $1.5M | 13,921 | 0.6% |
| Point Biopharma Global Inc | EQUITIES | 730541109 | $1.4M | 198,477 | 0.6% |